May. 14 at 5:46 PM
$OMID
OMID Holdings Inc.’s 2024 report shows revenue surged to
$247.6K, nearly doubling YoY. Q4 marked a turning point with a
$2.1K gross profit—its first positive margin in over a year. Still, high COGS (
$499.8K) keep the company unprofitable. Strategic efforts include new THC/skincare launches, trade show presence, and a streamlined web structure with active B2C and consolidated B2B portals. Challenges remain: the “Yield” sign persists on OTCMarkets despite filings, and a new update is still pending. With a GMP-certified facility and AATAC partnership, 2025 could be decisive if cost control and disclosures improve. DYOR Always